Life360, Inc. (LIF) Peer Comparison
$42.37
$1.30
(3.17%)
As on 19-Oct-2026 16:00EDT
Market cap
$3,346 Mln
Revenue (TTM)
$573 Mln
P/E Ratio
23.9
P/B Ratio
5.4
Div. Yield
0 %
Edit
| Life360, Inc. (LIF) | Waystar Holding Corp. (WAY) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
3,346 | 5,246 | 81 | 10 | 2 |
Revenue ($ Mln) |
573 | 1,206 | -- | 4 | 2 |
Net Profit ($ Mln) |
147.29 | 134.79 | 0.89 | -0.12 | -18.75 |
Net Margin (%) |
25.72 | 11.18 | -- | 1.20 | -1,003.19 |
RoE (%) |
25.36 | 3.43 | 4.09 | 54.17 | -130.74 |
Price to Earnings |
23.88 | 40.24 | 68.07 | -- | -- |
Price-To-Book |
5.41 | 1.19 | -- | 1,802.81 | 0.52 |
Income Statement ($ Mln)
| Life360, Inc. (LIF) | Waystar Holding Corp. (WAY) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
489.48 | 1,099.28 | -- | 2.05 | 0.38 |
|
Cost of Revenue
|
108.64 | 348.16 | -- | 1.39 | 0.35 |
|
Gross Profit
|
380.84 | 751.12 | -- | 0.66 | 0.03 |
|
Operating Expenses
|
362.02 | 501.81 | -- | 0.93 | 7.90 |
|
Operating Profit (EBIT)
|
18.83 | 249.31 | -- | -0.27 | -7.90 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
32.66 | 171.76 | -0.01 | -0.28 | -7.99 |
|
Provision for Tax
|
-118.17 | 59.67 | -- | -- | -- |
|
Profit after Tax (Net Income)
|
150.83 | 112.09 | -0.01 | -0.28 | -8.88 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Life360, Inc. (LIF) | Waystar Holding Corp. (WAY) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
548.18 | 3,878.83 | 0.02 | -0.17 | 16.80 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
314.72 | 1,688.21 | 0.00 | 0.37 | 14.16 |
|
Current Liabilities
|
96.79 | 218.06 | 0.18 | 0.51 | 0.65 |
|
Total Liabilities
|
959.69 | 5,785.10 | 0.20 | 0.71 | 31.61 |
Assets ($ Mln)
| Life360, Inc. (LIF) | Waystar Holding Corp. (WAY) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
353.58 | 5,476.69 | 0.20 | 0.26 | 18.60 |
|
Current Assets
|
606.10 | 308.41 | 0.00 | 0.45 | 13.01 |
|
Total Assets
|
959.69 | 5,785.10 | -- | 0.71 | 31.61 |
|
Total Debt*
|
310.75 | 1,490.93 | -- | 0.35 | 6.45 |
|
Net Current Assets
|
509.31 | 90.35 | -- | -0.14 | 12.36 |
Cashflow ($ Mln)
| Life360, Inc. (LIF) | Waystar Holding Corp. (WAY) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
88.63 | 309.67 | -- | -0.21 | -7.00 |
|
Cash Flow from Investing Activities
|
-35.33 | -680.90 | -- | -- | -0.71 |
|
Cash from Financing Activities
|
282.07 | 243.45 | -- | 0.16 | 18.35 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Life360, Inc. (LIF) | Waystar Holding Corp. (WAY) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
24.76 | 2.31 | -- | -2,636.14 | -68.86 |
|
ROE (%)
|
33.27 | 3.22 | -- | 170.10 | -91.85 |
|
ROA (%)
|
21.53 | 2.16 | -- | -39.73 | -51.60 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
30.81 | 10.20 | -- | -13.81 | -2,324.08 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Life360, Inc. (LIF) | Waystar Holding Corp. (WAY) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
0.32 | 0.17 | -- | 0.00 | -1.00 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
3,411.35 | 686.09 | -- | 0.00 | -56.99 |
|
EPS Growth (%)
|
33.35 | 6.32 | -- | -- | -2.94 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Life360, Inc. (LIF) | Waystar Holding Corp. (WAY) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
36.22 | 57.66 | -- | -- | -0.04 |
|
Price / Book Value
|
9.97 | 1.67 | -- | -- | 0.02 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
113.94 | 20.18 | -- | -- | 0.75 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Life360, Inc. (LIF) | Waystar Holding Corp. (WAY) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.57 | 0.38 | -- | -2.13 | 0.38 |
|
Short term debt to equity ratio
|
0.00 | 0.01 | -- | -0.75 | 0.03 |
|
Current Ratio
|
6.26 | 1.41 | 0.00 | 0.88 | 20.13 |
|
Quick Ratio
|
6.16 | -- | -- | -- | 8.53 |
|
Interest Coverage
|
-- | 3.22 | -- | -31.30 | -53.75 |
Operating Efficiency Ratios
| Life360, Inc. (LIF) | Waystar Holding Corp. (WAY) | Westlin Corporation (WSTN) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
16.94 | 16.69 | -- | -- | 0.26 |
|
Asset Turnover
|
0.70 | 0.21 | -- | 2.88 | 0.02 |
|
Receivable days
|
53.89 | 55.08 | -- | -- | 33.47 |
|
Inventory Days
|
30.13 | -15.38 | -- | -- | 332.90 |
|
Payable days
|
23.32 | 51.57 | -- | 80.44 | 202.97 |
|
Cash Conversion Cycle
|
60.70 | -14.70 | -- | -- | 163.39 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
